IL17A and peripheral neuropathy: The novelty of our study lies in the systematic identification and subsequent validation of the IL-17 signaling pathway as an important mechanism for LA’s effect specifically in the context of nab-PTX-induced peripheral neuropathy, which to our knowledge, has not been reported before.